undamentalytics Newsletter
Sign in

Agilon Health, Inc. income statement

In fiscal 2025, Agilon Health, Inc. reported revenue of $5.93bn, down 2.1% on the year before, operating income of −$463m (a -7.8% margin) and net income of −$391m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue7941,2181,5212,3884,3166,0615,9335,920
General and administrative123137428208286269239259
Operating income−107−57−372−105−232−292−463−309
Interest expense98647677
Income before tax−115−62−383−91−194−249−404−251
Income tax−01121111
Net income−283−60−406−107−263−260−391−232
Diluted shares (average)295m323m373m408m409m411m414m—
EBITDA−65−43−358−92−212−268−435−281

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AGL vs OPCHAGL vs ASTHAGL vs AMN

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Agilon Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agilon Health, Inc.